Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2023 Earnings Call Transcript February 20, 2024
Halozyme Therapeutics, Inc. reports earnings inline with expectations. Reported EPS is $0.82 EPS, expectations were $0.82. Halozyme Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Hello and Welcome to the Halozyme Fourth Quarter and Fiscal Year 2023 Financial and Operating Results Conference Call....
